Consumer Information for: ZINBRYTA
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
ZINBRYTA is a prescription medicine used to treat adults with active relapsing remitting forms of multiple sclerosis (RRMS) who have tried 1 or more MS medicines that have not worked well enough. In multiple sclerosis, your immune system mistakenly attacks the protective sheath (called myelin) around the nerves in the central nervous system (brain and spinal cord). This stops nerves from working properly. People with RRMS will have repeated attacks (relapses) of physical symptoms. These symptoms vary from patient to patient but usually involve physical problems such as difficulty walking, vision and balance problems. Symptoms may disappear completely after the relapse is over, but over time, some problems may remain between relapses, that can interfere with your daily activities.
What it does
ZINBRYTA is a humanized monoclonal antibody. Monoclonal antibodies are proteins which bind to a unique site (called an antigen) on cells. ZINBRYTA binds to an antigen, called CD25, which is present at high levels on certain cells of your immune system. ZINBRYTA works on your immune system so that it may not attack your nervous system as much.
What the medicinal ingredient is
daclizumab beta
What the non-medicinal ingredients are
polysorbate 80, sodium chloride, sodium succinate (anhydrous), succinic acid, water for injection.
What dosage form it comes in
Daclizumab beta 150 mg/mL solution for injection in pre-filled pen or pre-filled syringe
Each pack contains one or three* pre-filled pen(s)/pre-filled syringe(s) with a pre-attached
needle, ready to inject.
*not all pack sizes may be available
When it should not be used
- You have liver problems.
- You have, or have a history of, autoimmune-related liver problems including autoimmune hepatitis.
- You have previously had allergic reactions to any form of daclizumab, or any of the other ingredients listed in section ‘What are the ingredients in ZINBRYTA’.
Warnings and precautions
Serious Warnings and Precautions
ZINBRYTA can cause serious liver problems (including autoimmune-related liver problems and acute liver failure)
that may lead to death. Liver injury, including autoimmune hepatitis, can occur at any time during treatment with
ZINBRYTA, with cases reported up to 4 months after the last dose of ZINBRYTA. Your healthcare provider should
do blood tests to check your liver before you start using ZINBRYTA, every month while you are using ZINBRYTA,
and monthly for 6 months after you stop using ZINBRYTA (see Liver problems below). Your healthcare provider
should check your test results before your next dose.
Some people using ZINBRYTA develop immune-mediated disorders (a condition where the body’s immune system
attacks healthy cells in their body) and other immune system problems such as skin reactions, low red blood cell
count, intestinal problems (colitis).
Because of the risk of serious liver problems, ZINBRYTA is only available through a controlled distribution
program called Biogen ONE® Support Program. Under this program, only prescribers and pharmacies registered
with the program are able to prescribe and dispense the product. In addition, ZINBRYTA can only be dispensed
(one injection per month) to patients who are registered and informed about the risks of ZINBRYTA and meet all
the conditions of the Biogen ONE® Support Program including compliance with monthly monitoring and
assessment of liver enzymes before the next dose of ZINBRYTA.
To register to the Biogen ONE® Support Program, please call 1-855-676-6300.
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ZINBRYTA. Talk about any health conditions or problems you may have, including:
- Have, or have a history of, liver problems. ZINBRYTA may cause liver problems (see ‘Other warnings you should know about and serious side effects’).
- Have or had a history of skin problems including eczema or psoriasis.
- Have an active infection, such as pneumonia.
- Have tuberculosis.
- Have depression or a history of depression
- Are planning to receive a vaccine
- Are pregnant or plan to become pregnant. It is not known if ZINBRYTA will harm your unborn baby.
- Are breastfeeding or plan to breastfeed. It is not known if ZINBRYTA passes into your breast milk.
Other warnings you should know about:
ZINBRYTA can cause serious side effects, including:
Liver problems
ZINBRYTA may cause serious liver problems (including autoimmune-related liver problems)
that may lead to death. Your doctor should carry out blood tests to test your liver function before
you begin treatment with ZINBRYTA and before your next monthly dose during treatment and
up to 6 months after stopping treatment (as side effects may occur after treatment).
- It is important that you have these regular blood tests.
You will be given a Patient Alert Card with further information. Keep the Patient Alert Card
with you during treatment and up to 6 months after stopping treatment with ZINBRYTA. When
you have any medical treatment, even if it is not for your MS, show the Patient Alert Card to
your doctor.
If you experience any of the following, contact your healthcare provider or doctor immediately
as they may be life-threatening;
- Unexplained nausea (feeling sick to your stomach)
- Vomiting (being sick)
- Stomach pain
- Increased tiredness
- Loss of appetite (anorexia)
- Your skin or the whites of your eyes turn yellow
- Dark (tea-colored) urine
These symptoms may suggest problems with your liver. If you do develop liver problems your
MS doctor may interrupt your treatment with ZINBRYTA and refer you to a liver specialist (see
Serious side effects).
Tell your healthcare professional about all the medicines you take, including any drugs,
vitamins, minerals, natural supplements or alternative medicines.
Immune system problems
Some people using ZINBRYTA develop immune-mediated disorders (a condition where the
body’s immune system attacks healthy cells in their body) and other immune system problems
involving one or more organs.
Call your healthcare provider right away if you have any of the following symptoms, as
they may be life-threatening:
- Skin reactions such as rash, pain in your joints, skin irritation or tender, painful, or swollen lymph nodes.
- Low red blood cell count. Symptoms can include paleness, increased tiredness, dark urine, shortness of breath, or the whites of the eyes or the skin turn yellow.
- Intestinal problems (colitis). Symptoms can include fever, stomach pain, blood in your stools, or diarrhea that does not go away.
- Any new and unexplained symptoms affecting any part of your body.
If you plan to get vaccinated:
If you need to receive a vaccine, seek your doctor’s advice first. Vaccination with live vaccines
is not recommended during treatment and up to 4 months after discontinuation of treatment.
Consider any necessary immunization with live vaccines prior to treatment with ZINBRYTA.
Pregnancy and breastfeeding and fertility:
Before starting ZINBRYTA speak to your doctor if you are pregnant or plan to become pregnant.
Tell your doctor if you become pregnant during your treatment with ZINBRYTA. If you want to
breastfeed talk to your doctor first.
Interactions with this medication
Proper use of this medication
ZINBRYTA 150mg is injected subcutaneously (under the skin) every month.
- You can inject into your thigh, stomach (abdomen), or back of upper arm.
- Try to keep to a particular day of the month to help remember your injection. For example, inject on the first day of each month.
You should receive a blood test to test your liver function every month before your next dose
during your treatment with ZINBRYTA, and for 6 months after you have stopped using
ZINBRYTA. It is very important that you should have this blood test. Try to keep to a
scheduled day for your blood test. Contact your doctor if you think you may have missed a blood
test.
Use ZINBRYTA exactly as your healthcare provider tells you.
Your doctor or nurse should train you how to inject your ZINBRYTA before you use it for the
first time. Read and follow the advice given in the “INSTRUCTIONS FOR USE”
If you have trouble handling the syringe, ask your doctor or nurse who may be able to help.
Children and adolescents
ZINBRYTA has not been tested in children and adolescents below 18 years old.
Elderly
ZINBRYTA has not been tested in people older than 65 years old. If you are over 65 your doctor
may still prescribe ZINBRYTA.
Usual dose
ZINBRYTA 150mg is injected subcutaneously (under the skin) monthly.
Overdose
Missed Dose
Try to keep to a particular day of the month to help remember your injection. If you miss a dose and it is within 2 weeks of the missed dose, inject that dose as soon as you can, and then stay on your original monthly dosing schedule. If it is more than 2 weeks from the missed dose, skip the missed dose and inject your next dose at your regular time the next month. Do not use two injections to make up for a missed injection.
Side effects and what to do about them
ZINBRYTA can cause side effects, including serious side effects. Do not try to treat these side
effects yourself, but contact your doctor or nurse. Some side effects may require your doctor to
interrupt your treatment and refer you to a specialist.
These are not all the possible side effects you may feel when taking ZINBRYTA. If you
experience any side effects not listed here, contact your healthcare professional. Please also see
Warnings and Precautions.
Serious side effects: get medical help
Liver problems
If you get any of these symptoms:
- Unexplained nausea (feeling sick to your stomach)
- Vomiting (being sick)
- Stomach pain
- Increased tiredness
- Loss of appetite (anorexia)
- Your skin or the whites of your eyes turn yellow
- Dark (tea-colored) urine
Contact your doctor. They may be signs of a serious liver problem.
Blood tests
Your doctor will carry out blood tests before starting treatment, every month during treatment
and up to 6 months after stopping treatment with ZINBRYTA. If your test results show a
problem with your liver, your doctor may interrupt or stop your treatment and refer you to a liver
specialist.
It is very important that you have these regular blood tests, even if you are feeling well.
Please refer to the ZINBRYTA Patient Alert Card for more information about these side-effects.
Other important side effects
Allergic reactions or serious problems that may affect different parts of the body such as
your liver, kidneys, heart or blood.
These can be very serious and can cause death. Call your healthcare provider right away if you
have any of the following symptoms while using ZINBRYTA: fever, rash, swelling of the face,
tongue or throat, trouble breathing, etc.
Skin reactions
ZINBRYTA may cause skin reactions including severe rash. Contact your doctor if you develop
a wide-spread rash.
Depression and suicide
Some people taking ZINBRYTA may develop depression, depressed mood, or suicidal thoughts.
Contact your doctor right away if you experience irritability (getting upset easily), depression
(feeling unusually sad, feeling hopeless or bad about yourself), nervousness, anxiety, sleeping a
lot more or a lot less than usual, feel tired or sleepy all the time, or thoughts of hurting yourself
or suicide.
Infections
ZINBRYTA may increase your risk of developing a serious infection such as a respiratory tract
infection (pneumonia, bronchitis) or a urinary tract infection. Call your healthcare provider if
you have symptoms of an infection. Talk to your healthcare provider before you get vaccinations
while using ZINBRYTA.
Low red blood cell counts (autoimmune hemolytic anemia)
Some people taking ZINBRYTA may develop a condition that lowers red blood cell counts.
Symptoms can include paleness, increased tiredness, dark urine, shortness of breath, or the
whites of the eyes or the skin turn yellow. These could be signs of a serious condition. Contact
your doctor immediately if you experience any of these symptoms.
Intestinal problems (colitis)
Some people taking ZINBRYTA may develop colitis. Symptoms can include diarrhea that does
not go away, stomach pain, fever or blood in your stools. Contact your doctor if you experience
any of these.
Very common side effects (may affect more than 1 in 10 people)
- Infections of the airways, such as colds (Nasopharyngitis, upper respiratory tract infection)
Common side effects (may affect up to 1 in 10 people)
- Flu (Influenza)
- Sore throat, tonsillitis (Pharyngitis, Laryngitis)
- Runny nose (Rhinitis)
- Lung infections (Bronchitis, Pneumonia)
- Skin rashes, including inflamed, irritated, itchy, dry or peeling skin (Dermatitis,Eczema, Psoriasis)
- Skin infection (Folliculitis, Acne)
- Decreases in the amount of certain cells (lymphocytes) in your blood
- Increases in body temperature or fever
- Increases in liver enzymes in the blood (these will show up in blood tests)
- Inflamed or enlarged lymph nodes (Lymphadenopathy, Lymphadenitis)
- Depression
- Diarrhea
- Anemia (symptoms may include feeling weak or tired, or appearing pale)
Call your doctor if you have any side effect that bothers you or that does not go away.
| Symptom / effect | Talk to your healthcare professional Only if severe | Talk to your healthcare professional In all cases | Stop taking drug and get immediate medical help |
|---|---|---|---|
| COMMON (may affect up to 1 in 10
people) Liver problems |
|||
| unexplained nausea (feeling sick to your stomach) | ✔ | ||
| vomiting (being sick) | ✔ | ||
| stomach pain | ✔ | ||
| increased tiredness | ✔ | ||
| loss of appetite (anorexia) | ✔ | ||
| your skin or the whites of your eyes turn yellow | ✔ | ||
| dark (tea-colored) urine | ✔ | ||
| COMMON (may affect up to 1 in 10
people) Allergic reactions |
|||
| fever | ✔ | ||
| rash | ✔ | ||
| swelling of the face, tongue or throat | ✔ | ||
| trouble breathing | ✔ | ||
| COMMON (may affect up to 1 in 10
people) Skin reactions |
|||
| severe rash | ✔ | ||
| COMMON (may affect up to 1 in 10
people) Infections |
|||
| fever | ✔ | ||
| chills | ✔ | ||
| swollen glands | ✔ | ||
| UNCOMMON (may affect up to 1 in
100 people) Depression and suicide |
|||
| irritability (getting upset easily) | ✔ | ||
| depression (feeling unusually sad | ✔ | ||
| feeling hopeless or bad about yourself) | ✔ | ||
| nervousness | ✔ | ||
| anxiety | ✔ | ||
| sleeping a lot more or a lot less than usual | ✔ | ||
| feel tired or sleepy all the time | ✔ | ||
| thoughts of hurting yourself or suicide | ✔ | ||
| UNCOMMON (may affect up to 1 in
100 people) Lymphadenopathy |
|||
| inflamed or enlarged lymph nodes | ✔ | ||
| UNCOMMON (may affect up to 1 in
100 people) Autoimmune hemolytic anemia (low red blood cell count) |
|||
| increased tiredness | ✔ | ||
| dark urine | ✔ | ||
| paleness | ✔ | ||
| shortness of breath | ✔ | ||
| the whites of the eyes or the skin turn yellow | ✔ | ||
| UNCOMMON (may affect up to 1 in
100 people) Colitis |
|||
| diarrhea that does not go away | ✔ | ||
| stomach pain | ✔ | ||
| fever | ✔ | ||
| blood in your stools | ✔ | ||
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
Reporting side effects
You can help improve the safe use of health products for Canadians by reporting serious and
unexpected side effects to Health Canada. Your report may help to identify new side effects
and change the product safety information.
3 ways to report:
- Faire une déclaration en ligne au MedEffect;
- By calling 1-866-234-2345 (toll-free);
- By completing a Consumer Side Effect Reporting Form and sending it by:
- Fax to 1-866-678-6789 (toll-free), or
- Mail to: Canada Vigilance Program
Health Canada, Postal Locator 1908C
Ottawa, ON
K1A 0K9
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
How to store
Keep this medicine out of reach and sight of children.
Check the expiration date printed on either the pre-filled pen/syringe, or pre-filled pen/syringe
pack. Do not use the pre-filled pen/syringe past the expiration date. The expiry date refers to the
last date of that month.
Keep the ZINBRYTA pre-filled pen/syringe in its original package to protect from light. Keep
the pack closed until you need to use a new pen /syringe.
Store in a refrigerator, between 2°C and 8°C (36°F and 46°F).
Do not freeze or expose to high temperatures. Discard if it has been frozen.
If a refrigerator is not available, ZINBRYTA pens/syringes can be stored at room temperature
(up to 30°C/86°F) in the original pack for up to 30 days. Make sure the time ZINBRYTA is out
of the refrigerator is no more than 30 days. If ZINBRYTA has been outside of the refrigerator for
more than a total of 30 days or if you are not sure how long ZINBRYTA has been at room
temperature, throw the pen/syringe away (see Disposal). Do not place ZINBRYTA back into
the refrigerator after warming to room temperature.
Do not use your pre-filled pen if it has been dropped or is visibly damaged.
Do not use this medicine if you notice any of the following;
- If the pen/syringe is cracked or broken.
- If the solution is cloudy or you can see particles floating in it.
- If the solution is any other color than colorless to slightly yellow.
Disposal:
Ask your pharmacist how to dispose of used pens/syringes and any unused medicines.
Dispose of any unused medicine according to community guidelines.
Pens/syringes should not be disposed of in a recycling bin.
More information
ZINBRYTA™ - Solution for injection, for subcutaneous use, pre-filled pen
ZINBRYTA™ - Solution for injection, for subcutaneous use, pre-filled syringe
Read the Instructions for Use before you start using ZINBRYTA and each time you get a refill of
your prescription. There may be new information. This information does not take the place of
talking to your doctor or nurse about your medical condition or your treatment.
It is very important that you should receive a blood test to test your liver function before you
begin treatment with ZINBRYTA and before your next monthly dose during your treatment with
ZINBRYTA, and for 6 months after you have stopped using ZINBRYTA.
Note:
- Before you use the ZINBRYTA pre-filled syringe for the first time, your doctor or nurse should show you or your caregiver how to prepare and inject your ZINBRYTA prefilled syringe the right way.
- If you experience difficulty or have questions about how to inject, call the Biogen ONE® Support Program at 1-855-676-6300.
- ZINBRYTA pre-filled syringe is for use under the skin only (subcutaneous)
- Each ZINBRYTA pre-filled syringe can be used 1 time only. Do not share your ZINBRYTA pre-filled syringe with anyone else. By sharing the needle, you may give an infection to them or get an infection from them.
Supplies needed for your ZINBRYTA injection:
ZINBRYTA pre-filled syringe Figure A

Additional supplies which are not included in the pack (See Figure B):
- Alcohol wipe
- Gauze pad
- Adhesive bandage
- 1 sharps container for throwing away used needles and ZINBRYTA pre-filled syringes. See “Disposing of your used ZINBRYTA pre-filled syringes” at the end of these instructions.
- a well-lit area and a clean, flat surface to work on, like a table

Parts of your ZINBRYTA pre-filled syringe (See Figure C)

Note:
- Before you prepare your injection, take your ZINBRYTA pre-filled syringe out of
the refrigerator and let it come to room temperature for at least 30 minutes.
Do not use external heat sources such as hot water to warm the ZINBRYTA prefilled
syringe.
Do not use more than one pre-filled syringe per calendar month. - The Finger Flange will allow you to better grip the syringe and should remain attached.
Preparing for Injection
Step 1: Place Supplies and Wash Hands
- Find a well-lit, clean, flat surface to work on, like a table. Collect all the supplies you will need to give yourself or to receive an injection.
- Wash your hands with soap and water and dry thoroughly.
Step 2: Check Your ZINBRYTA Pre-filled Syringe
- Check the expiration date printed on
your ZINBRYTA pre-filled syringe
(See Figure D).
Do not use ZINBRYTA pre-filled
syringe past the expiration date. - Check that your ZINBRYTA medicine
is colorless or slightly yellow (See Figure E).
Do not use ZINBRYTA pre-filled
syringe if the liquid is cloudy, or has
floating particles in it. - You might see air bubbles in your ZINBRYTA medicine. This is normal and does not need to be expelled prior to your injection.
| Giving the Injection Step 3: Choose and Clean the Injection Site
|
![]() |
Step 4: Firmly Remove Needle Cover
|
![]() |
Step 5: Gently Pinch the Injection Site
|
![]() |
Step 6: Inject Medication
|
![]() |
Step 7: Remove Pre-filled Syringe from Site
Caution -do not recap the ZINBRYTA
pre-filled syringe. You could get a
needle stick injury.
Do not reuse the ZINBRYTA pre-filled
syringe. |
![]() |
After the Injection
Step 8: Disposing of your used ZINBRYTA Pre-filled Syringe
- Throw away the used ZINBRYTA pre-filled syringe into a special secure container, such
as a sharps bin, or according to community guidelines. Check with your doctor,
pharmacist or nurse about the right way to throw away the container.
Do not dispose of your used pre-filled syringe or disposal container in your household
trash unless your community guidelines permit this.
Step 9: Care for Injection Site
- If needed, apply a gauze pad or adhesive bandage to the injection site.
General Warnings
Do not reuse your ZINBRYTA pre-filled syringe.
Do not share your ZINBRYTA pre-filled syringe.
- Keep ZINBRYTA pre-filled syringe and all medications out of reach of children.
Storage
- Recommended storage is controlled refrigeration 2°C to 8°C (36°F to 46°F) in the closed original carton to protect from light.
- If needed, ZINBRYTA may be stored in the closed original carton without refrigeration
up to 30°C (up to 86°F) for up to 30 days.
Do not place your ZINBRYTA pre-filled syringe back into the refrigerator after warming
to room temperature
Do not freeze or expose to high temperatures.
ZINBRYTA™ - Solution for injection, for subcutaneous use, pre-filled pen
Read the Instructions for Use before you start using ZINBRYTA and each time you get a refill of
your prescription. There may be new information. This information does not take the place of
talking to your doctor or nurse about your medical condition or your treatment.
It is very important that you should receive a blood test to test your liver function before you
begin treatment with ZINBRYTA and before your next monthly dose during your treatment with
ZINBRYTA, and for 6 months after you have stopped using ZINBRYTA.
Note:
- If you experience difficulty or have questions regarding how to use the pen, call Biogen ONE® Support Program at 1-855-676-6300.
- Before you use your pen for the first time, your doctor or nurse should show you or your caregiver how to prepare and inject your pen the right way.
- Your pen is for use under the skin only (subcutaneous).
- Each pen can be used 1 time only.
- Do not share your pen with anyone else to avoid giving an infection to them or getting an infection from them.
- Do not use more than 1 pen per month.
- Do not use your pen if it has been dropped or is visibly damaged.
Supplies needed for your ZINBRYTA Pen injection:
- 1 ZINBRYTA 150 mg Pen (see Figure A)
Before Use - Parts of your ZINBRYTA Pen (see Figure A):

Caution! Do not remove the cap until you are ready to inject. If you remove the cap,
do not re-cap the pen. Re-capping could cause the pen to lock.
Additional supplies which are not included in the pack (See Figure B):

Preparing for your injection:
- Remove your pen from the refrigerator.
- Remove your pen from the carton in your refrigerator 30 minutes before
giving your injection to allow it to warm to room temperature.
Do not use external heat sources, such as hot water, to warm your pen
- Remove your pen from the carton in your refrigerator 30 minutes before
giving your injection to allow it to warm to room temperature.
- Collect your supplies and wash your hands
- Find a well-lit area and a clean, flat surface to work on, like a table and collect all the supplies you will need to give yourself, or to receive, an injection.
- Wash your hands with soap and water.
- Check your ZINBRYTA Pen (See Figure C)
- Check the injection status window. You should see green stripes.
- Check the expiration date.
- Check the medication window and make sure the ZINBRYTA medicine is colorless to slightly yellow.
Do not use your pen if:
- You do not see the green stripes in the injection status window.
- It is past the expiration date.
- The liquid is cloudy or has floating particles in it.
Note: You might see air bubbles in the medication window. This is normal and will not affect your dose.

- Choose and clean your injection site
- Choose an injection site in your
thigh, abdomen, or the back of your
upper arm (See Figure D).
Do not inject into an area of your body where the skin is irritated, red, bruised, tattooed, infected, or scarred. - Wipe your skin with an alcohol
wipe.
Do not touch or blow on this area again before giving your injection. - Let your injection site dry on its own before injecting your dose.

- Choose an injection site in your
thigh, abdomen, or the back of your
upper arm (See Figure D).
- Remove the ZINBRYTA Pen cap
- Pull the pen cap straight off and set it aside for disposal after your injection (See Figure E). Your pen is ready to inject.
Warning! Do not touch, clean or
manipulate the needle cover. You
could get a needle stick or the pen
may lock.
Caution! Do not recap your pen.
This could lock the pen.
- Give your injection
- Hold your pen over your chosen
injection site. Make sure you can see the
green stripes in the injection status
window (See Figure F).
Note: Be ready to inject prior to pressing your pen down on your injection site, as the needle cover will lock when it is lifted from the site. - Firmly press and hold down your pen on your injection site until you hear the clicking sounds start (See Figure G).
- Continue to hold your pen firmly down
on your injection site until the clicking
sounds have stopped (see Figure H).
Do not lift your pen off your injection site until the clicking sounds stop and you see green checkmarks in the injection status window.

- Hold your pen over your chosen
injection site. Make sure you can see the
green stripes in the injection status
window (See Figure F).
- Remove your ZINBRYTA Pen from your injection site
- After the clicking sound has stopped, lift your pen from your injection site. The needle cover will extend to cover the needle and will lock (See Figure I).

- Check to make sure you have received your full dose of ZINBRYTA
(see Figure J)
- Check the injection status window. You should see green checkmarks.
- Check the medication window. You should see a yellow plunger.

Giving your injection:
If you do not hear clicking sounds and/or you do not see green checkmarks in the injection status window after attempting to inject, your pen may have locked and you should call the Biogen ONETM Support Program at 1-855-676-6300.
After Use – Parts of your ZINBRYTA Pen (see Figure K):

Note: After the pen has been removed from the injection site, the needle cover will lock to
protect against needle stick injury. Do not recap your pen.
After your injection:
9. Dispose of your used ZINBRYTA Pens
- Throw away the used ZINBRYTA pens into a special secure container, such as a
sharps bin, or according to community guidelines. Check with your doctor,
pharmacist or nurse about the right way to throw away the container.
Do not dispose of your used pens or disposal container in your household trash unless your community guidelines permit this.
Do not recap your ZINBRYTA Pen.
10. Care for injection site
- Apply a gauze pad or adhesive bandage to the injection site, if needed.
Storage
- Recommended storage is controlled refrigeration 2°C to 8°C (36°F to 46°F) in the closed original carton to protect from light.
- If needed, ZINBRYTA may be stored in the closed original carton without refrigeration up to 30°C (up to 86°F) for up to 30 days.
- Do not place your ZINBRYTA pen back into the refrigerator after warming to room temperature
- Do not freeze or expose to high temperatures.
- Keep ZINBRYTA pen and all medications out of reach of children.
If you want more information about ZINBRYTA:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; the manufacturer’s website www.biogen.ca, or by calling 1-866-477-3462.
This leaflet was prepared by Biogen Canada Inc.
Last Revised: January 2018
Related Drug Products
| Product name | DIN | Company name | Active ingredient(s) & strength |
|---|---|---|---|
| LETROZOLE | 02524244 | SIVEM PHARMACEUTICALS ULC | LETROZOLE 2.5 MG |




